Name
OÜ Apteek Elite
Registry code
10850722
VAT number
EE100746594
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
15.03.2002 (22)
Financial year
01.01-31.12
Capital
8 420.00 €
Activity
47731 - Dispensing chemist in specialised stores
655 974 €
26 131 €
4%
3 275 €
(estimate is approximate)
102 555 €
1
Submitted
No tax arrears
25%
17%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Piret Roost 20.02.1960 (64) | 51% - 4 295.00 EUR | Board member | Direct ownership | |
| Sander Sõritsa 21.01.1996 (28) | 49% - 4 125.00 EUR | - | Direct ownership | |
| OÜ FERTIILSUSE KESKUS 10240426 | - | - | - | Founder |
| Lea Arrak 26.03.1955 (69) | - | - | - | Founder |
| 2019 29.06.2020 | 2020 30.06.2021 | 2021 28.06.2022 | 2022 29.06.2023 | 2023 28.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 366 258 € | 374 411 € | 467 043 € | 645 123 € | 655 974 € |
| Net profit (loss) for the period | 6 190 € | 1 020 € | 14 552 € | 36 109 € | 26 131 € |
| Profit Margin | 2% | 0% | 3% | 6% | 4% |
| Current Assets | 71 651 € | 53 296 € | 77 255 € | 126 205 € | 157 851 € |
| Fixed Assets | 0 € | 0 € | 0 € | 0 € | 0 € |
| Total Assets | 71 651 € | 53 296 € | 77 255 € | 126 205 € | 157 851 € |
| Current Liabilities | 9 753 € | 27 533 € | 36 940 € | 49 781 € | 55 296 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 61 898 € | 25 763 € | 40 315 € | 76 424 € | 102 555 € |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 159 178.19 € | 7 833.33 € | 5 541.55 € | 2 |
| 2023 Q4 | 167 881.9 € | 6 396.85 € | 4 764.64 € | 2 |
| 2023 Q3 | 153 987.23 € | 8 886.48 € | 5 823.4 € | 2 |
| 2023 Q2 | 191 435.43 € | 8 186.94 € | 4 835.73 € | 2 |
| 2023 Q1 | 167 343.89 € | 7 265.12 € | 4 738.75 € | 2 |
| 2022 Q4 | 162 573.45 € | 7 829.09 € | 5 244.77 € | 2 |
| 2022 Q3 | 143 392.88 € | 9 545.1 € | 6 094.72 € | 3 |
| 2022 Q2 | 196 314.33 € | 9 945.77 € | 4 975.91 € | 3 |
| 2022 Q1 | 157 985.59 € | 8 986.17 € | 3 964.42 € | 3 |
| 2021 Q4 | 143 491.99 € | 8 826.7 € | 3 922.83 € | 2 |
| 2021 Q3 | 105 766.01 € | 8 994.06 € | 5 374.49 € | 2 |
| 2021 Q2 | 116 390.62 € | 6 239.81 € | 3 744.02 € | 2 |
| 2021 Q1 | 102 438.23 € | 6 600.43 € | 4 005.31 € | 2 |
| 2020 Q4 | 116 213.62 € | 12 424.37 € | 3 579.03 € | 2 |
| 2020 Q3 | 96 048.4 € | 6 103.56 € | 4 407.84 € | 2 |
| 2020 Q2 | 78 251.16 € | 4 111.06 € | 2 636.85 € | 2 |
| 2020 Q1 | 98 018.35 € | 10 450.81 € | 3 522.92 € | 2 |
